This study assessed whether certain clinicopathologic variables could explain the impact of
race on outcome in 86 patients who had severe lupus nephritis and were available for long-
term follow-up after participating in a prospective, controlled, clinical trial. Fifty-four (63%)
patients were white, 21 (24%) were black, and 11 (13%) were categorized as other. The
proportion of patients with anti-Ro, anti-nRNP, and anti-Sm was significantly greater among
black patients. Biopsies with segmental active proliferative and necrotizing lesions that …